|
NAA16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.312400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.013800E-01 |
| Normal-vs-Stage2 |
4.650000E-01 |
| Normal-vs-Stage3 |
2.906000E-01 |
| Normal-vs-Stage4 |
2.553600E-01 |
| Stage1-vs-Stage2 |
4.242400E-01 |
| Stage1-vs-Stage3 |
3.693400E-01 |
| Stage1-vs-Stage4 |
4.561200E-01 |
| Stage2-vs-Stage3 |
2.105400E-01 |
| Stage2-vs-Stage4 |
1.812770E-01 |
| Stage3-vs-Stage4 |
8.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.347800E-01 |
| Normal-vs-AfricanAmerican |
6.999400E-01 |
| Normal-vs-Asian |
3.591600E-01 |
| Caucasian-vs-AfricanAmerican |
7.852000E-01 |
| Caucasian-vs-Asian |
1.172840E-01 |
| AfricanAmerican-vs-Asian |
1.285240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.898600E-01 |
| Normal-vs-Female |
2.200600E-01 |
| Male-vs-Female |
1.246420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.681800E-01 |
| Normal-vs-Extreme_Weight |
6.330200E-01 |
| Normal-vs-Obese |
5.046400E-01 |
| Normal-vs-Extreme_Obese |
3.244400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.666200E-01 |
| Normal_Weight-vs-Obese |
6.078000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.206600E-01 |
| Extreme_Weight-vs-Obese |
2.638800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.320400E-01 |
| Obese-vs-Extreme_Obese |
3.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.544000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.840000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.698000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.873600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.135200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.222200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.422160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.537300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.391500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.756000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.909900E-02 |
| Normal-VS-Type2 PRCC |
1.303850E-03 |
| Normal-VS-KIRP CIMP |
6.034800E-01 |
| Normal-VS-Unclassified PRCC |
3.587200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.92669999346629E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.779000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.946600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.504650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.320700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.965400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.544830E-01 |
| Normal-vs-N1 |
8.030600E-01 |
| Normal-vs-N2 |
5.539600E-02 |
| N0-vs-N1 |
1.674410E-01 |
| N0-vs-N2 |
3.362600E-01 |
| N1-vs-N2 |
1.723610E-01 |
|
|
